Three NHS trusts have selected Wolters Kluwer Health’s clinical decision tool as the company expands its customer base in the UK.
UpToDate is an evidence-based knowledge system that helps clinicians make the right decisions at the point of care. It gives clinicians access to peer-reviewed treatment recommendations and the latest best practice guidelines for more than 12,000 clinical topics and 9,500 graduate recommendations.
North Tees and Hartlepool NHS Foundation Trust, Portsmouth Hospitals University NHS Trust and Calderdale and Huddersfield NHS Foundation Trust have opted to use the solution. They join seven NHS trusts deployed UpToDate during the Covid-19 pandemic.
In addition to opting to use UpToDate, Calderdale and Huddersfield have also selected to use Wolters Kluwer’s Lexicomp drug information tool, which provides drug information and clinical content for pharmacists and clinicians.
The other new British customers of Wolters Kluwer are:
- Advanz Pharma (UpToDate)
- SWMI: Information on Southwestern Drugs (Lexicomp)
- Belfast Health and Social Care Trust (Lexicomp) Regional Drug and Poison Information Service
Denise Basow, president and CEO of clinical efficacy at Wolters Kluwer, said: “Clinical teams are accustomed to dealing with complex medical conditions on a daily basis, often in highly pressurized environments when making the right decision is critical. Access to decision support resources, such as UpToDate and Lexicomp, ensures they have the most up-to-date and accurate information available, helping them to deliver the best care everywhere. ”
“Incorporating UpToDate into the clinical workflow, through electronic patient registration, also helps improve the decision-making process and, at the same time, improves patient safety, quality of care, and clinical outcomes.”
“This, together with UpToDate accreditation by the Federation of Royal UK Medical Associations (CPR), allows clinicians to use UpToDate as part of their personal professional development, integrated into the clinical workflow.”